Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
08/2005
08/04/2005WO2005071393A2 Detecting element and detection method
08/04/2005WO2005071387A1 Methods for diagnosis and pronosis of cancers of epithelial origin
08/04/2005WO2005071134A1 Method and apparatus for monitoring optical characteristics of thin films in a deposition process
08/04/2005WO2005071116A1 Modulation of hsv infection
08/04/2005WO2005071102A2 Methods of detecting methyl transferase activity and methods of screening for methyl transferase activity modulators
08/04/2005WO2005071101A1 Treatment of hepatitis c infection by increasing stat1 methylation
08/04/2005WO2005071100A2 Method for determination of protein modifying or demodifying activity and suitable materials thereof
08/04/2005WO2005071099A1 Enzyme chip and utilization thereof
08/04/2005WO2005071098A1 Method of screening substance improving lipid metabolism
08/04/2005WO2005071095A2 Fluorogenic kinase assays and substrates for kinases and phosphatases
08/04/2005WO2005071081A1 Eosinophil-deficient transgenic animals
08/04/2005WO2005071065A1 Method for studying functional interactions between sensory neurons and keratinocytes or melanocytes
08/04/2005WO2005071056A1 Biochip and method for inspecting functionality of sample solution using it
08/04/2005WO2005070970A1 Connective tissue growth factor signaling
08/04/2005WO2005070969A1 Protein immobilization method and quantification method
08/04/2005WO2005070968A1 Protein immobilization method and quantification method
08/04/2005WO2005070964A1 Method of isolating monocytes
08/04/2005WO2005070961A1 Human organic solute transporters
08/04/2005WO2005070935A1 Use of phthalocyanines as marking substances for liquids
08/04/2005WO2005070456A2 Diagnosing and treating female reproductive tract or chilhood cancer with pmsa antibodies
08/04/2005WO2005070448A2 Methods of use for secreted frizzled-related protein 3 (sfrp-3) in the prevention and treatment of disease
08/04/2005WO2005070447A2 M-csf muteins and uses thereof
08/04/2005WO2005070287A1 Adjustment of sensors or measuring systems
08/04/2005WO2005070148A2 Methods of using high affinity atiii variants
08/04/2005WO2005070122A2 Mechanosensitive ion channels and methods of use
08/04/2005WO2005070037A2 Automated media optimization technology
08/04/2005WO2005070021A2 Microarray analysis of post-translational modifications
08/04/2005WO2005070014A2 Enzymatic methionine assay
08/04/2005WO2005069975A2 Lysyl oxidase-like 1 (loxl1) and elastogenesis
08/04/2005WO2005069943A2 Method and apparatus for calibrating a frequency domain reflectometer
08/04/2005WO2005069934A2 Peptide identification
08/04/2005WO2005069906A2 Methods and compositions relating to vascular endothelial growth factor and th2 mediated inflammatory diseases
08/04/2005WO2005069900A2 Npc1l1 (npc3) and methods of identifying ligands thereof
08/04/2005WO2005069891A2 System and method for expression proteomics based on isotope ratio modification
08/04/2005WO2005069889A2 Hydroxyl functional surface coating
08/04/2005WO2005069883A2 Method and apparatus for transmission line and waveguide testing
08/04/2005WO2005069872A2 High throughput pharmaceutical screening using drosophila
08/04/2005WO2005069855A2 Modulators of angiogenesis
08/04/2005WO2005069852A2 Primary central nervous system tumor specific behab isoforms
08/04/2005WO2005069737A2 Method and system for detecting analytes
08/04/2005WO2005069725A2 Fluorescence-based adp detection system
08/04/2005WO2005069724A2 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease
08/04/2005WO2005061532A8 Pathogenic infection detection compositions and methods
08/04/2005WO2005060661A3 METHODS AND MATERIALs FOR ASSESSING PROSTATE CANCER THERAPIES
08/04/2005WO2005059929A3 Magnetic rod apparatus and method for manipulating magnetic particles for detecting analytes
08/04/2005WO2005059085A3 Method and device for division of a biological sample by magnetic effect
08/04/2005WO2005058865A3 Assay for entactogens
08/04/2005WO2005054495A3 Ligand-containing micelles and uses thereof
08/04/2005WO2005052587A3 Diagnostics and therapeutics for diseases associated with potassium channel, subfamily k, member 7 (kcnk7)
08/04/2005WO2005052586A3 Diagnostics and therapeutics for diseases associated with potassium channel, subfamily k, member 3 (kcnk3)
08/04/2005WO2005052541A3 Method of separation and collection and apparatus therefor
08/04/2005WO2005051990A3 Polynucleotides overexpressed in breast cancer cells, compositions and methods for the therapy and diagnosis of breast cancer
08/04/2005WO2005047876A3 System and method for sensing and analyzing gases
08/04/2005WO2005046455A3 Methods for identifying or monitoring a patient with increased risk of cardiovascular calcification
08/04/2005WO2005045435A3 METHOD FOR DISTINGUISHING T(11q23)/MLL-POSITIVE LEUKEMIAS FROM T(11q23)MLL NEGATIVE LEUKEMIAS
08/04/2005WO2005045432A3 Method for distinguishing prognostically definable aml
08/04/2005WO2005043165A3 Specific method for cancer detection
08/04/2005WO2005043164A3 Method for distinguishing cbf-positive aml subtypes from cbf-negative aml subtypes
08/04/2005WO2005043163A3 Method for distinguishing who classified aml subtypes
08/04/2005WO2005043109A3 Sers diagnostic platforms, methods and systems including microarrays, biosensors and biochips
08/04/2005WO2005042715A3 Angiogensis models using nestin-expressing stem cells to image nascent blood vessels
08/04/2005WO2005041750A3 Method for identifying compounds that affect expression of tryptophan hydroxylase isoform 2
08/04/2005WO2005036170A3 Device for separating and/ analysing several molecular targets dissolved in a complex mixture
08/04/2005WO2005030033A3 Fluid sample test device
08/04/2005WO2005029033A3 Cyanide sensing compounds and uses thereof
08/04/2005WO2005026689A3 Immunoassay device with immuno-reference electrode
08/04/2005WO2005026328A3 Cpt resistant cell line
08/04/2005WO2005024041A3 Alkyl-substituted vinyl pyridines for mass-coded tagging of proteins
08/04/2005WO2005024040A3 Target and method for inhibition of bacterial rna polymerase: minimized derivatives of peptide antibiotic mccj25
08/04/2005WO2005022150A3 Assay methods and materials for distinguishing analytes and analyte analogues
08/04/2005WO2005022121A3 Measurement of nitrogen content in a gas mixture by transforming the nitrogen into a substance detectable with nondispersive infrared detection
08/04/2005WO2005018420A3 Method of constructing a biosensor
08/04/2005WO2005016954A3 Immunologic activity measure(s) for t “helper” on-associated conditions
08/04/2005WO2005010481A3 Preparation and use of gold glyconanoparticles
08/04/2005WO2004108009A3 Method and kit for assessing risk for bovine respiratory disease
08/04/2005WO2004104168A3 Mrbs as modifiers of the rb pathway and methods of use
08/04/2005WO2004090547A3 Metastatic colorectal cancer signatures
08/04/2005WO2004089295A3 Homogeneous and heterogeneous assay methods using nucleation centers and novel covalent chemistries for the rapid measurement of phosphorylation and de-phosphorylation
08/04/2005WO2004087070A3 METHODS OF IDENTIFYING COMPOUNDS THAT TARGET tRNA SPLICING ENDONUCLEASE AND USES OF SAID COMPOUNDS AS ANTI-FUNGAL AGENTS
08/04/2005WO2004080385A3 Compositions and methods for diagnosing and treating an inflammation
08/04/2005WO2004080273A3 Compositions and methods for diagnosing and treating prostate cancer
08/04/2005WO2004073651A3 Identifying inhibitors of intracellular protein fibrillization
08/04/2005WO2004071393A3 Diagnostics and therapeutics for diseases associated with glucagon-like peptide 1 receptor (glp1r)
08/04/2005WO2004065408A3 Enhancement of humoral immune responses using a novel myeloid accessory cell
08/04/2005WO2004058841A3 Synthesis and use of inorganic polymer sensor for detecting nitroaromatic compounds
08/04/2005WO2004053487A8 METHOD OF DIAGNOSIS,TREATMENT AND USEFUL AGENTS FOR CONDITIONS CHARACTERISED BY MODULATION IN THE LEVEL OF ACTIVIN βC
08/04/2005WO2004046686A3 Method and system for analyzing test devices
08/04/2005WO2004043238A3 Biomarkers for intra-amniotic inflammation
08/04/2005WO2004027419A3 Method of diagnosing colorectal adenomas and cancer using proton magnetic resonance spectroscopy
08/04/2005WO2004027374A3 Method for using division arrested cells in screening assays
08/04/2005WO2004025266A3 Method and apparatus for sorting particles
08/04/2005WO2004016726A9 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
08/04/2005WO2004005316A3 Prevention and treatment of hcv infection employing antibodies directed against conformational and linear epitopes
08/04/2005WO2003095610A3 Directed evolution method of generating enhanced folding polypeptide variants
08/04/2005WO2003067217A3 Skin cell biomarkers and methods for identifying biomarkers using nucleic acid microarrays
08/04/2005WO2002035441A3 System method, and computer software product for controlling biological microarray scanner
08/04/2005US20050172363 Nematode PPPT-like sequences
08/04/2005US20050172352 Using presence of allelic mutation in protein kinase c gene as diagnostic indication of heart disease
08/04/2005US20050172350 Identifying modulators of purine/pyrimidine phosphoribosyl transferase (PPPT) polypeptides; treating and preventing microorganismal infection in crop plants
08/04/2005US20050172344 Using hippocampal cells as models for identifying modulators for prevention and/or treatment of nervous system disorders
1 ... 2064 2065 2066 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 2078 2079 2080 2081 2082 2083 2084 ... 3937